570 556 captures · dernière capture : 3 mai 2026
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
386 223 captures · dernière capture : 14 avr. 2026
243 880 captures · dernière capture : 28 avr. 2026
ARCHIVED Emergency Contact Information Form This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to use the form, you must use the alternate format below. (PDF Version - 12 K) (Microsoft Word…
Applications and service standards for drug establishment licences (GUI-0127): Overview Overview How to prepare and submit a DEL application How we manage DEL applications Reviewing DEL applications Annual review of DELs Glossary and definitions References Deficiencies Contact us…
Guidance on veterinary antimicrobial sales reporting Drug Establishment Licensing Bulletin #147, March 13, 2023 On this page What to report Definitions Contact us What to report The Veterinary Antimicrobial Sales Reporting (VASR) system, which collects sales of veterinary…
Publication of updated Annex 1 to the Good manufacturing practices guide - Manufacture of sterile drugs (GUI-0119) Drug Establishment Licensing Bulletin 148, August 24, 2023 In a 2020 notice Health Canada informed stakeholders of the Pharmaceutical Inspection Co-operation Scheme…
Consultation opens for the Good manufacturing practices guide: Manufacture of biologics (GUI-0027) Drug Establishment Licensing Bulletin 141, September 20, 2023 On this page About the consultation Overview of key changes How to participate About the consultation Annex 2 to the…
Annex 7 to the good manufacturing practices guide - selected non-prescription drugs (GUI-0066) Drug Establishment Licensing Bulletin 135, September 29, 2023 On September 29, 2023, the Health Product Compliance Directorate posted the following annex to the Good manufacturing…
ARCHIVED Notice: Health Products and Food Branch Inspectorate - Establishment Licensing - Important Upcoming Changes (PDF Version - 608 K) Contact Information Upcoming Changes Repeal of Establishment Licence Expiry Date Effective April 1, 2011, an establishment licence will no…
ARCHIVED Notice to Stakeholders: Foreign Sites - Expiring; Change to Expiry Calculation 1) Renewing Foreign Sites that are Nearing Expiration 2) New: Changes to Calculation of Period of Validity/Expiry for Foreign Site Evidence To: Drug Establishment Licence (DEL) Holders Changes…
Letter to Stakeholders - Responsibilities and Obligations with Respect to the Good Manufacturing Practices Health Canada reminds drug manufacturers about the importance of good manufacturing practices (GMP) On February 17, Health Canada sent a letter reminding all Drug…
Inspections Health Canada Good Manufacturing Practices (GMP) Inspection List As an ongoing commitment to openness and transparency, Health Canada is publishing information regarding inspections related to drugs. The Health Canada Good Manufacturing Practices (GMP) Inspection List…
Version préliminaire : la couverture est limitée au corpus actuel et les fonctionnalités peuvent changer.
